PL3634957T3 - Modulatory receptora NMDA, zawierające je kompozycje oraz zastosowanie tych związków w leczeniu chorób ośrodkowego układu nerwowego - Google Patents
Modulatory receptora NMDA, zawierające je kompozycje oraz zastosowanie tych związków w leczeniu chorób ośrodkowego układu nerwowegoInfo
- Publication number
- PL3634957T3 PL3634957T3 PL18727799T PL18727799T PL3634957T3 PL 3634957 T3 PL3634957 T3 PL 3634957T3 PL 18727799 T PL18727799 T PL 18727799T PL 18727799 T PL18727799 T PL 18727799T PL 3634957 T3 PL3634957 T3 PL 3634957T3
- Authority
- PL
- Poland
- Prior art keywords
- compositions
- compounds
- treatment
- nervous system
- same
- Prior art date
Links
- 102000004868 N-Methyl-D-Aspartate Receptors Human genes 0.000 title 1
- 108090001041 N-Methyl-D-Aspartate Receptors Proteins 0.000 title 1
- 210000003169 central nervous system Anatomy 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1754993A FR3067028B1 (fr) | 2017-06-06 | 2017-06-06 | Modulateurs de recepteurs nmda, compositions les comprenant et utilisation de ces composes dans le traitement de maladies impliquant le systeme nerveux central |
| PCT/EP2018/064093 WO2018224359A1 (fr) | 2017-06-06 | 2018-05-29 | Modulateurs de recepteurs nmda, compositions les comprenant et utilisation de ces composés dans le traitement de maladies impliquant le systeme nerveux central |
| EP18727799.1A EP3634957B1 (fr) | 2017-06-06 | 2018-05-29 | Modulateurs de recepteurs nmda, compositions les comprenant et utilisation de ces composés dans le traitement de maladies impliquant le systeme nerveux central |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3634957T3 true PL3634957T3 (pl) | 2022-01-03 |
Family
ID=60138428
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL18727799T PL3634957T3 (pl) | 2017-06-06 | 2018-05-29 | Modulatory receptora NMDA, zawierające je kompozycje oraz zastosowanie tych związków w leczeniu chorób ośrodkowego układu nerwowego |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US11247982B2 (pl) |
| EP (1) | EP3634957B1 (pl) |
| JP (1) | JP7160844B2 (pl) |
| CA (1) | CA3065622A1 (pl) |
| DK (1) | DK3634957T3 (pl) |
| ES (1) | ES2892175T3 (pl) |
| FR (1) | FR3067028B1 (pl) |
| PL (1) | PL3634957T3 (pl) |
| WO (1) | WO2018224359A1 (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117624015B (zh) * | 2023-12-06 | 2024-08-16 | 广东医科大学 | 一种取代靛红-褪黑激素衍生物及其制备方法和应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR056317A1 (es) | 2005-04-20 | 2007-10-03 | Xenon Pharmaceuticals Inc | Compuestos de oxindol y composicion farmaceutica |
| KR101692275B1 (ko) * | 2010-02-11 | 2017-01-04 | 노오쓰웨스턴 유니버시티 | ２차 구조 안정화된 ｎｍｄａ 수용체 조절제 및 그의 용도 |
| AU2013216354B2 (en) | 2012-02-02 | 2017-08-31 | Idorsia Pharmaceuticals Ltd | 4-(benzoimidazol-2-yl)-thiazole compounds and related aza derivatives |
| WO2013123272A1 (en) | 2012-02-16 | 2013-08-22 | Allergan, Inc. | Compositions and improved soft tissue replacement methods |
| WO2014055142A1 (en) | 2012-06-20 | 2014-04-10 | Cocrystal Discovery, Inc. | Inhibitors of hepatitis c virus polymerase |
| WO2014025942A1 (en) | 2012-08-09 | 2014-02-13 | Emory University | Nmda receptor modulators and uses related thereto |
| WO2014106238A1 (en) | 2012-12-31 | 2014-07-03 | Fang, Qun, Kevin | Heterocyclic compounds and methods of use thereof |
| TWI671299B (zh) | 2014-04-14 | 2019-09-11 | 愛爾蘭商健生科學愛爾蘭無限公司 | 作為ｒｓｖ抗病毒化合物之螺脲化合物 |
-
2017
- 2017-06-06 FR FR1754993A patent/FR3067028B1/fr not_active Expired - Fee Related
-
2018
- 2018-05-29 CA CA3065622A patent/CA3065622A1/fr active Pending
- 2018-05-29 ES ES18727799T patent/ES2892175T3/es active Active
- 2018-05-29 DK DK18727799.1T patent/DK3634957T3/da active
- 2018-05-29 PL PL18727799T patent/PL3634957T3/pl unknown
- 2018-05-29 US US16/619,263 patent/US11247982B2/en not_active Expired - Fee Related
- 2018-05-29 JP JP2019568253A patent/JP7160844B2/ja active Active
- 2018-05-29 EP EP18727799.1A patent/EP3634957B1/fr active Active
- 2018-05-29 WO PCT/EP2018/064093 patent/WO2018224359A1/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| US11247982B2 (en) | 2022-02-15 |
| ES2892175T3 (es) | 2022-02-02 |
| DK3634957T3 (da) | 2021-10-04 |
| EP3634957A1 (fr) | 2020-04-15 |
| US20200385363A1 (en) | 2020-12-10 |
| FR3067028A1 (fr) | 2018-12-07 |
| WO2018224359A1 (fr) | 2018-12-13 |
| JP2020524666A (ja) | 2020-08-20 |
| CA3065622A1 (fr) | 2018-12-13 |
| FR3067028B1 (fr) | 2019-07-12 |
| EP3634957B1 (fr) | 2021-07-07 |
| JP7160844B2 (ja) | 2022-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL255509B (en) | Compounds as modulators of ccr2, pharmaceutical preparations containing them and their use in the treatment of diseases | |
| IL271117B (en) | Diazabicyclic mutated imidazopyrimidines and their use in the treatment of respiratory disorders | |
| IL272095A (en) | 17-alpha-21-cortexolone diesters for use in the treatment of tumors and as glucocorticoid receptor modulators | |
| PL3224254T3 (pl) | Podstawione indazole, sposób ich wytwarzania, preparaty farmaceutyczne je zawierające, oraz ich zastosowanie do wytwarzania leków | |
| CA2956871C (en) | Compounds active towards bromodomains | |
| PH12018500586A1 (en) | Farnesoid x receptor agonists and uses thereof | |
| LT3377637T (lt) | Kompozicijos, skirtos panaudoti žaizdų, sutrikimų ir odos ligų gydymo būduose | |
| IL256684B (en) | Medicinal compounds and preparations for the treatment of social disorders and substance use disorders | |
| SG10202013034QA (en) | Compositions, devices, and methods for the treatment of alcohol use disorder | |
| MX2018000352A (es) | 4-azaindoles sustituidos y su uso como moduladores del receptor glun2b. | |
| TN2017000074A1 (en) | Methyl-and trifluoromethyl-substituted pyrrolopyridine modulators of rorc2 and methods of use thereof | |
| EP3337482A4 (en) | TRANSDERMAL FORMULATIONS FOR THE DISTRIBUTION OF BERBERIN COMPOUNDS AND THEIR USE IN THE TREATMENT OF BERBER INDEPENDENT ILLNESSES AND DISORDERS | |
| MX2017006437A (es) | Compuestos espiroisoquinolin-1,4'-piperidinicos con actividad multimodal contra el dolor. | |
| GB201715194D0 (en) | Compounds and their therapeutic use | |
| EP3302530A4 (en) | Cdh26 based therapeutic agents and their use | |
| EP3344233A4 (en) | TRANSDERMAL FORMULATIONS FOR THE DELIVERY OF DOXYCLYCLIN AND THEIR USE IN THE TREATMENT OF DOXYCLYCLIN-RELATED ILLNESSES AND SUFFERING | |
| IL274177A (en) | Medical substances, their preparation and diagnostic method | |
| IL249860A0 (en) | Pharmaceutical preparations, methods for their preparation and their use for the treatment of cancer | |
| PL3634957T3 (pl) | Modulatory receptora NMDA, zawierające je kompozycje oraz zastosowanie tych związków w leczeniu chorób ośrodkowego układu nerwowego | |
| PL3341481T3 (pl) | Kompozycja antysensowna mikrorna-328 i zastosowanie terapeutyczne | |
| ZA201801945B (en) | Compositions and methods for the treatment of parkinson's disease | |
| SMT202100683T1 (it) | Composti etinilici, loro preparazione e loro uso terapeutivo per il trattamento della malaria | |
| HK40019799A (en) | Use of glucocorticoid receptor modulators in the treatment of catecholamine-secreting tumors | |
| HK40024485A (en) | Composition for use in the treatment of epilepsy | |
| AU2015902659A0 (en) | Therapeutic compounds and compositions for treating social disorders and substance use disorders |